Evidence map›Paper›PMID 31882578›Full record

ArticleScientific reports2019

Author Correction: Circulating Apolipoprotein L1 is associated with insulin resistance-induced abnormal lipid metabolism.

Kenji Nishimura, Taichi Murakami, Toshihiro Sakurai, Masashi Miyoshi, Kiyoe Kurahashi, Seiji Kishi, Masanori Tamaki, Tatsuya Tominaga, Sumiko Yoshida, Kojiro Nagai and 4 more

Abstract readPublished Erratum
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Kenji NishimuraDepartment of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan.
Taichi MurakamiDepartment of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan. c-tamurakami@eph.pref.ehime.jp.
Toshihiro SakuraiFaculty of Health Sciences, Hokkaido University, Sapporo, Japan.
Masashi MiyoshiDivision of Medical Technology, Tokushima University Hospital, Tokushima, Japan.
Kiyoe KurahashiDepartment of Hematology, Endocrinology and Metabolism, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Seiji KishiDepartment of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan.
Masanori TamakiDepartment of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan.
Tatsuya TominagaDepartment of Chronomedicine, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan.ORCID http://orcid.org/0000-0001-9985-6113
Sumiko YoshidaDepartment of Hematology, Endocrinology and Metabolism, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Kojiro NagaiDepartment of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan.
Hideharu AbeDepartment of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan.
Shu-Ping HuiFaculty of Health Sciences, Hokkaido University, Sapporo, Japan.ORCID http://orcid.org/0000-0001-9973-6461
Kazuhiko KotaniDivision of Community and Family Medicine, Center for Community Medicine, Jichi Medical University, Shimotsuke, Japan.
Toshio DoiDepartment of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31882578
PMCPMC6934493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.